Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N. J. Meropol
Use of a Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients With Stage II Colon Cancer: Impact on Quality-Adjusted Life Expectancy and Costs.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Patient–physician Discordance in Goals of Care for Patients With Advanced Cancer
Current Oncology
Oncology
Related publications
Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer
Scientific Reports
Multidisciplinary
Adjuvant Chemotherapy Does Not Provide Survival Benefits to Elderly Patients With Stage II Colon Cancer
Scientific Reports
Multidisciplinary
Effect of Adjuvant Chemotherapy on Stage II Colon Cancer: Analysis of Korean National Data
Cancer Research and Treatment
Cancer Research
Oncology
A Multigene Assay Is Prognostic of Survival in Patients With Early-Stage Lung Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
2-Year Single Center Clinical Experience in Patients With Colon Cancer Stage II and III Receiving Adjuvant Chemotherapy
Scripta Scientifica Medica
Prm240 - Estimation of Quality-Adjusted Life Expectancy of Oral Cancer Patients: Integration of Lifetime Survival Adjusted With Repeated Quality of Life Measurements
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Screening Mammography Use and Chemotherapy Among Female Stage II Colon Cancer Patients: A Retrospective Cohort Study
BMC Health Services Research
Health Policy
Adjuvant Chemotherapy for Stage II Right-Sided and Left-Sided Colon Cancer: Analysis of SEER-Medicare Data
Annals of Surgical Oncology
Oncology
Surgery
Estimation of Quality-Adjusted Life Expectancy in Patients Under Prolonged Mechanical Ventilation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
